Predictive Value of Cetuximab-Induced Skin Toxicity in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NECK

Background: Skin toxicity is a common adverse event during cetuximab (Cmab) treatment. However, few reports have investigated the correlation between skin toxicity and the efficacy of Cmab in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN). Methods: We...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Oncol
Main Authors: Uozumi, Shinya, Enokida, Tomohiro, Suzuki, Shinya, Nishizawa, Aya, Kamata, Hayato, Okano, Tomoka, Fujisawa, Takao, Ueda, Yuri, Okano, Susumu, Tahara, Makoto, Yamaguchi, Masakazu
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2018
Assuntos:
Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6300475/
https://ncbi.nlm.nih.gov/pubmed/30619755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2018.00616
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares